The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...
“Insulin injections remain a daily burden for many patients,” said Shingo Ito, an associate professor at Kumamoto University ...
For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug ...
Treating children with mild diabetic ketoacidosis (DKA) using subcutaneous (SC) insulin aspart was linked to lower hospital costs and better efficacy of DKA management, compared with using intravenous ...
The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...
India Today on MSN
Oral insulin breakthrough could end daily injections
A novel peptide platform from Japan may finally overcome insulin's biggest barrier-surviving digestion – offering hope for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results